BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6142862)

  • 1. Significance of encapsulated Bacteroides melaninogenicus and Bacteroides fragilis groups in mixed infections.
    Brook I; Walker RI
    Infect Immun; 1984 Apr; 44(1):12-5. PubMed ID: 6142862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
    Brook I
    J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism between penicillin, clindamycin, or metronidazole and gentamicin against species of the Bacteroides melaninogenicus and Bacteroides fragilis groups.
    Brook I; Coolbaugh JC; Walker RI; Weiss E
    Antimicrob Agents Chemother; 1984 Jan; 25(1):71-7. PubMed ID: 6142680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prophylactic antibiotics upon mixed infections with Bacteroides fragilis.
    Brook I
    Surg Gynecol Obstet; 1987 Dec; 165(6):491-5. PubMed ID: 3317944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of growth of aerobic and facultative bacteria in mixed infections with Bacteroides species.
    Brook I
    Infect Immun; 1985 Dec; 50(3):929-31. PubMed ID: 4066037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo protection of penicillin-susceptible Bacteroides melaninogenicus from penicillin by facultative bacteria which produce beta-lactamase.
    Brook I; Pazzaglia G; Coolbaugh JC; Walker RI
    Can J Microbiol; 1984 Jan; 30(1):98-104. PubMed ID: 6143608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenicity of encapsulated Bacteroides melaninogenicus group, B. oralis and B. ruminicola subsp. brevis in abscesses in mice.
    Brook I; Gillmore JD; Coolbaugh JC; Walker RI
    J Infect; 1983 Nov; 7(3):218-26. PubMed ID: 6141205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of antimicrobial therapy on mixed infections with Bacteroides species. Is eradication of the anaerobes important?
    Brook I
    J Infect; 1991 Jan; 22(1):27-35. PubMed ID: 2002230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between Fusobacterium species and other flora in mixed infection.
    Brook I; Walker RI
    J Med Microbiol; 1986 Mar; 21(2):93-100. PubMed ID: 2936888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of encapsulated Bacteroides asaccharolyticus and Bacteroides fragilis on the growth of aerobic and facultative bacteria in mixed infections.
    Brook I
    J Surg Res; 1989 Jul; 47(1):92-5. PubMed ID: 2739405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo efficacies of quinolones and clindamycin for treatment of infections with Bacteroides fragilis and/or Escherichia coli in mice: correlation with in vitro susceptibilities.
    Brook I
    Antimicrob Agents Chemother; 1993 May; 37(5):997-1000. PubMed ID: 8517727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial interference by oropharynegeal and clinical isolates of anaerobic bacteria.
    Murray PR; Rosenblatt JE
    J Infect Dis; 1976 Sep; 134(3):281-5. PubMed ID: 10336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteroides melaninogenicus. Its recovery from tonsils of children with acute tonsillitis.
    Brook I; Gober AE
    Arch Otolaryngol; 1983 Dec; 109(12):818-20. PubMed ID: 6139104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metronidazole and spiramycin in abscesses caused by Bacteroides spp. and Staphylococcus aureus in mice.
    Brook I
    J Antimicrob Chemother; 1987 Nov; 20(5):713-8. PubMed ID: 3429373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Streptococcus faecalis on the growth of Bacteroides species and anaerobic cocci in mixed infection.
    Brook I
    Surgery; 1988 Jan; 103(1):107-10. PubMed ID: 3122348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenicity of the Bacteroides fragilis group.
    Brook I
    Ann Clin Lab Sci; 1989; 19(5):360-76. PubMed ID: 2679351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of cephalosporins for prophylaxis and therapy of polymicrobial infection in mice.
    Brook I
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1531-5. PubMed ID: 8363386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
    Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR
    J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
    Brook I; Ledney GD
    J Antimicrob Chemother; 1994 Feb; 33(2):243-52. PubMed ID: 8182005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid detection and identification of Bacteroides fragilis and Bacteroides melaninogenicus by immunofluorescence.
    Weissfeld AS; Sonnenwirth AC
    J Clin Microbiol; 1981 Apr; 13(4):798-800. PubMed ID: 6112238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.